Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [C]‑BI 425809 in Healthy Males.

Clin Drug Investig

Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.

Published: April 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989795	PMC
http://dx.doi.org/10.1007/s40261-022-01134-w	DOI Listing

Publication Analysis

oral dose

correction absolute

absolute bioavailability

bioavailability absorption

absorption distribution

distribution metabolism

metabolism excretion

excretion 425809

425809 administered

administered oral

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!